Benzo [d]isoselenazol-3-ones N-substituted with sterically hindered diamagnetic and paramagnetic five-or six-membered nitroxides or their precursors, including ring-opened diselenides, exhibit synergism in glutathione peroxidase (GPx) activity.
Introduction
Glutathione peroxidases (GPx) are selenoenzymes that protect various organisms from oxidative stress by catalyzing the reduction of hydroperoxides at the expense of glutathione (GSH) (eqn 1). 
The GPx superfamily contains four types of enzymes, the classical cytosolic GPx (cGPx), phospholipid hydroperoxide GPx (PHGPx), plasma GPx (pGPx) and gastrointestinal GPx (giGPx), all of which require selenium in their active sites for catalytic activity.
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The biological role of these key enzymes in the antioxidant defense system comprises not only detoxification, by reducing an overproduction of hydroperoxides, but also the regulation of intracellular signalling pathways 10 and enzyme activities, such as that of 5-lipoxygenase. 11 To overcome the intrinsic difficulties associated with the use of an enzyme as a drug, a number of low-molecular-weight organoselenium mimics 12-14 have been developed for the reduction of hydroperoxides, which include the well-known GPx mimic ebselen (1) 15,16 (Scheme 1.) and related compounds having direct Se-N bond, 17-22 cyclic compounds without any direct Se-N bond 23,24 aphenylselenoketones, 25 and diaryl diselenides having Se · · · N or Se · · · O intramolecular interactions.
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Ebselen (1) is a nontoxic compound at pharmacologically active concentrations, because its selenium is not bioavailable. It is mostly bound to proteins in the form of selenyl sulfides 15,16, 31 and it is metabolized predominantly into glucuronidated species. 32 Another important feature of ebselen is its inability to oxidize GSH in the presence of oxygen which normally leads to the uncontrolled production of superoxide and other free radical species. 33 Although a number of attempts have been made to design and synthesize ebselen-related GPx mimics based on substituent effects or isosteric replacements, most of them met with limited success. For example, the replacement of the phenyl ring in ebselen by a pyridine ring (2) resulted in a complete loss of catalytic activity. 20 In view of the potential applications of ebselen and related derivatives, we synthesized ebselen-based compounds by incorporating five-or six-membered N-heterocycles (as secondary amine connected to a diselenide "A form" or oxidized forms: N-hydroxyls "B form", N-oxyls "C form"). A number of non-selenium compounds having these substituents have been previously shown to posses cardioprotective activity. 34 It has also been shown that pyrroline-based compounds such as 3A exhibit markedly enhanced protection against ischemia/reperfusioninduced myocardial contractile dysfunction 35 and postischemic myocardial injury 36 probably due to their combined antioxidative and antiarrhythmic activities because the in vivo oxidation of 3A to 3C.
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In this work, we report the GPx activity of a series of closely related benzisoselenazolones and show, for the first time, that the synergistic effect of selenium and pyrroline substituents enhances the antioxidant activity of these compounds.
Results and discussion
Compounds 12C-18C were synthesized using the method described earlier, 38 i.e., by treating paramagnetic amines 5-11 in CHCl 3 with 2-chloroselenyl-benzoylchloride 4 39 at ambient temperature in the presence of 2 eq. Et 3 N. Amines 5, 34 6, 40 9, piperazine 21 46 with 4-nitrobenzylbromide afforded compound 22 the aromatic nitro group of which was reduced to yield amine 8 with ammonium formate in the presence of palladium on charcoal. The N-hydroxylamines 12-18 "B form" was achieved by refluxing the corresponding nitroxides 12-18 "C form" in EtOH saturated with HCl gas. 35 Reduction of the "C form", a nitroxide with Fe powder in glacial acetic acid 47 yielded the corresponding secondary amine diselenides 12-18 "A form" with opening of isoselenazole ring (Scheme 2).
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This ring opening takes place quite easily, even by reduction with ascorbic acid to selenol and oxidation during work-up or standing on air results in formation of a diselenide 23 (Scheme 3).
The ring opening followed by oxidation, e.g. structure of 12A-18A compounds was observed by 77 Se NMR measurements and data are in good agreement with earlier observations.
48
The GPx activity of new compounds for reduction of tBuOOH was screened spectrophotometrically at 340 nm as described earlier 49 with minor modifications. It is evident from data in Scheme 1 and Table 1 that most of the selenium compounds used in the present study are more potent than ebselen (1) . Interestingly, compounds 3A, 3B and 3C which lack selenium in the benzene anellated five-membered ring and 11 nitroxide precursor, exhibited some GPx activity, however they are about ten-fold less active than isoselenazolone derivatives (Scheme 1). The pyrroline-substituted compounds showed remarkable GPx activity when attached to the basic benzoselenazolone unit. For example, the activity of compound 12C (v 0 = 30.94 ± 0.86 lM × min −1 ), in which both pyrroline and isoselenazole units are present, is higher than the sum of their activities in the individual cases [v 0 (1 + 3C) = 14.37 ± 1.17 lM × min −1 ], suggesting a synergestic effect. The catalytic effect was demonstrated by changing the concentration of 12C and GSH (Table 1 ). The observed initial reduction rates (v 0 ) were directly proportional to the catalyst concentration and rate increases with increasing concentration of GSH and with excess amount of it, the expected saturation kinetics were observed (figure not shown). We can find the same case in the catalytic activity of compound 18C, which mimics the shape of ebselen with a six-membered ring connected to the nitrogen of isoselenasolone. This compound exhibits higher activity than ebselen (1) itself, confirming the role of the nitroxide based substituent. In other words, these two functionalities (isoselenazole and pyrroline/pyrrolidine/piperidine) individually show moderate effects on the reduction rate, however, when they are present together, the effect is supra-additive. The substitution pattern in the pyrroline ring also affects the reduction rate as observed for compounds 12A and 13A. Compound 13A, in which the pyrroline ring is attached to the phenyl ring at the 2-position, exhibits 2-fold higher activity than the 3-substituted 14A. The best initial rates were observed in the case of compounds with • C, 1 h, then K 2 CO 3 , 47-59%; (iv) 3-nitrophenyl boronic acid (1 eq.), Pd(PPh 3 ) 2 Cl 2 (5%), Ba(OH) 2 (1 eq.), dioxane-water, reflux, 3 h, 44%; (v) HCO 2 NH 4 (8 eq.), Pd/C, MeOH, 40
• C, 2 h, 35-43%; (vi) 4-nitrobenzylbromide (1 eq.), K 2 CO 3 , CHCl 3 , reflux, 4 h, 68%.
Scheme 3
Reduction of ebselen with ascorbic acid, followed by a spontaneous oxidation in an NMR tube. a polar spacer group e.g. an amide for 12C and an amine for 15A. The combined catalytic effect appears to be less in the case of apolar spacers: 16A with a methylene group and 14A with a phenyl group as a spacer have less catalytic activity. It is interesting to note that compounds 18B and 18C without linking groups also show similar GPx activity as 16C. This indicates that the ring size of nitroxide heterocycle does not affect the reaction rate. Seemingly, the oxidation state of nitroxide moiety does not effect the initial reaction rate neither the isoselenzolone/diselenide form; 12C is more effective than 12A, but as efficient as 15A.
Conclusions
In conclusion, we have shown that due to the synergistic effect of selenium and amino functionalities the modification of the basic ebselen unit by introducing redox-active pyrroline groups greatly enhances the GPx activity of ebselen. The results presented here suggest a new concept that sterically hindered amino groups near the active site of GPx may act synergistically with selenium during the reduction of hydroperoxides. Compounds like 12-18 with broad antioxidant activity may serve as "ROS and RNS sponges" and can be promising candidates in future therapy of free radical mediated diseases.
Experimental General
Melting points were determined with a Boetius micro melting point apparatus and are uncorrected. Elemental analyses (C, H, N, S) were performed on Carlo Erba EA 1110 CHNS elemental analyser. The IR (Specord 85) spectra were in each case consistent with the assigned structure. Mass spectra were recorded on a VG TRIO-2 instrument in the EI mode (70 eV, direct inlet), the source temperature was 210
• C, or an with Automass Multi instrument in the EI mode (70 eV, direct inlet). ESR spectra were obtained from 10 −5 molar solutions (CHCl 3 ), using an MS200 (Magnettech GMBH, Berlin) spectrometer. All radicals exhibited three equally spaced lines with a N = 15.1-15.5 G.
77 Se NMR spectra were obtained on either a Bruker AVACE400 NMR spectrometer in CDCl 3 48 were prepared according to published procedures, compound 1 was purchased from Calbiochem, compound 11A and other reagents were purchased from Aldrich. The GPx activity was followed spectrophotometrically at 340 nm on a Perkin-Elmer Lambda 35 UV-VIS Spectrophotometer. The test mixture contained GSH (1 mm), DTPA (1 mm), glutathione disulfide reductase (0.6 unit mL −1 ), and NADPH (0.1 mm) in 0.1 M potassium phosphate buffer, pH 7.3. GPx samples were added to the test mixture at room temperature and the reaction was started by the addition of tert-butyl hydroperoxide (1.2 mM, final concentration). The initial reduction rates were calculated from the rate of NADPH oxidation at 340 nm. Each initial rate was measured at least three times and calculated from the first 5-10% of the reaction by using 6.22 mM −1 cm −1 as the extinction coefficient for NADPH. For the peroxidase activity, the rates were corrected for the background reaction between t-BuOOH and GSH. 
General procedure for Ehrenkaufer reduction (7, 8)
To a stirred solution of nitro compound 20 or 22 (5.0 mmol) and HCO 2 NH 4 (2.52 g, 40 mmol) in MeOH (30 mL) at 40
• C under N 2 atmosphere 120 mg Pd/C (10%) was added and the mixture was stirred and refluxed until consumption of starting material (ca. 2 h). After cooling, the mixture was filtered through Celite and washed with methanol-water (40 mL : 10 mL). 
General procedure for synthesis of compounds 12C-18C
To a stirred solution of amine 5-11 (3.0 mmol) and Et 3 N (666 mg, 6.6 mmol) in CH 2 Cl 2 (20 mL) was added dropwise a solution of freshly prepared 2-(chloroseleno)benzoyl chloride 4 (762 mg, 3.0 mmol) in CH 2 Cl 2 (10 mL) over 5 min at rt and the mixture was stirred for a further 1 h. The organic phase was washed with brine (10 mL), dried (MgSO 4 ), filtered, evaporated and the residue was purified by flash column chromatography (CHCl 3 -Et 2 O or CHCl 3 -MeOH) to give compounds 12C-18C as orange-yellow solids in 35-73% yield.
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General procedure for synthesis of compounds 12B, 13B, 15B, 18B
A solution of compound 12C, 13C, 15C or 18C (0.5 mmol) was refluxed with EtOH (15 mL) (saturated with HCl) for 20 min. After cooling, the solvent was evaporated off and the residue was crystallized with acetone or Et 2 O to give title compounds as off-white or yellow solids in 68-82% yield. Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H -pyrrol-3 Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-ylmethyl) Hydroxy-2,2,6,6-tetramethylpiperidin-4-yl) 
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8.82; found: C 51.03, H 5.79, N 8.70%. 1 H NMR (400 MHz, D 2 O): d 7.96 (d, J = 7.6 Hz, 1H, ar CH), 7.89 (d, J = 7.2 Hz
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General procedure for synthesis of compounds 12A-18A
To a solution of nitroxide 12C-18C (1.0 mmol) in AcOH (8 mL) Fe powder (560 mg, 10 mmol) was added and the mixture was warmed up to 70
• C until the reaction started. The mixture was stirred at room temperature for 1 h, diluted with water (15 mL), decanted and the decanted aqueous solution made alkaline with solid K 2 CO 3 . The mixture was extracted with CHCl 3 (3 × 15 mL), dried (MgSO 4 ), filtered, evaporated and after chromatographic purification (CHCl 3 -MeOH) we got the title amines 12A-18A in 47-59% yield. 
